Viewing Study NCT01082094


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-27 @ 11:06 PM
Study NCT ID: NCT01082094
Status: COMPLETED
Last Update Posted: 2012-06-06
First Post: 2010-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure
Sponsor: Juventas Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ischemic heart failure View
None Congestive heart failure View
None Stromal cell-derived factor 1 View
None SDF-1 View
None Gene therapy View